수면무호흡증 치료 기기 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트와 예측(2026-2034년)

Growth Factors of sleep apnea devices Market

The global sleep apnea devices market is witnessing substantial growth due to the rising prevalence of sleep-related breathing disorders and increasing awareness regarding early diagnosis and treatment. Sleep apnea is a serious sleep disorder characterized by repeated interruptions in breathing during sleep, leading to reduced oxygen supply to the brain and other organs. This condition is more common among elderly individuals and patients suffering from comorbidities such as obesity, diabetes, hypertension, and cardiovascular disorders. According to Fortune Business Insights, the global sleep apnea devices market size was valued at USD 10.30 billion in 2025. The market is projected to grow from USD 11.00 billion in 2026 to USD 22.87 billion by 2034, exhibiting a CAGR of 9.59% during the forecast period.

North America dominated the global market in 2025, accounting for a 49.55% market share, driven by a high prevalence of obstructive sleep apnea (OSA), favorable reimbursement policies, and strong adoption of technologically advanced sleep apnea devices.

Market Drivers

The primary growth driver for the sleep apnea devices market is the rising prevalence of obstructive sleep apnea worldwide. According to data published by the National Center for Biotechnology Information (NCBI), approximately 936 million people globally suffer from mild to severe OSA, while 425 million people are affected by moderate to severe OSA. Sedentary lifestyles, obesity, poor sleep patterns, and increased stress levels are major contributors to the rising incidence of this condition.

In addition, the growing geriatric population and increasing burden of chronic diseases are leading to higher diagnosis and treatment rates. Awareness initiatives and campaigns by organizations such as the National Sleep Foundation are further encouraging early diagnosis and adoption of sleep apnea devices. The positive impact of COVID-19, which increased stress-related sleep disorders, also supported higher demand for diagnostic and therapeutic devices during and after the pandemic.

Market Trends

A key trend shaping the market is the growing adoption of technologically advanced and patient-friendly devices. Oral appliances such as mandibular advancement devices (MADs) are gaining popularity due to their comfort, portability, and non-invasive nature. In February 2024, the U.S. FDA approved AIO BREATHE, a new mandibular repositioning device, reflecting rising innovation in oral sleep apnea solutions.

Another significant trend is the increasing use of portable and cost-effective diagnostic devices, such as actigraphy systems and home sleep testing tools. These devices are gaining traction due to their affordability and suitability for home-based diagnosis, supporting the shift toward decentralized sleep apnea management.

Market Restraints

Despite strong growth prospects, the market faces challenges related to the high cost of sleep apnea devices. Continuous Positive Airway Pressure (CPAP) machines, which are widely used for OSA treatment, typically cost USD 600 to USD 800 in the U.S., making them expensive for uninsured patients. Limited reimbursement policies and high out-of-pocket expenses in developing countries further restrict device adoption, thereby hampering market growth.

Segmentation Analysis

By Device Type, the market is segmented into therapeutic devices and diagnostic devices. The therapeutic devices segment dominated the market with a 63.36% share in 2026, driven by increasing treatment rates and higher adoption of CPAP devices, oral appliances, and masks. Diagnostic devices are also witnessing growth due to the presence of a large undiagnosed population and increasing awareness regarding sleep disorder diagnosis.

By End User, the market is segmented into homecare & other settings and sleep laboratories & clinics. The homecare & other settings segment dominated with a 53.83% share in 2026, supported by the growing preference for home-based treatment and the launch of portable diagnostic devices. Sleep laboratories and clinics are also expected to grow steadily due to rising patient admissions and availability of skilled sleep technicians.

Regional Insights

North America led the market, with a market size of USD 5.11 billion in 2025, and the U.S. market projected to reach USD 5.10 billion by 2026.

Asia Pacific is expected to register the fastest CAGR, driven by rising prevalence of sleep apnea and increasing awareness. By 2026, Japan is projected to reach USD 0.47 billion, China USD 0.62 billion, and India USD 0.19 billion.

Europe is projected to grow steadily, with the UK market reaching USD 0.47 billion and Germany USD 0.73 billion by 2026, supported by high prevalence among the geriatric population.

Competitive Landscape

The market is highly competitive, with ResMed holding a dominant position due to its strong product portfolio and continuous innovation. Other key players include Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, SomnoMed, Compumedics Limited, and Braebon Medical Corporation. These companies focus on product launches, FDA approvals, and strategic acquisitions to strengthen their market presence.

Conclusion

In conclusion, the global sleep apnea devices market is expected to grow significantly from USD 10.30 billion in 2025 to USD 22.87 billion by 2034, driven by rising prevalence of obstructive sleep apnea, growing awareness, technological advancements, and increasing preference for home-based care. Although high device costs and reimbursement limitations remain key challenges, continuous innovation, expanding diagnostic capabilities, and increasing healthcare investments are expected to sustain robust market growth throughout the forecast period.

Segmentation

By Device Type

• Therapeutic Devices
  • Positive Airway Pressure Devices
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Bilevel Positive Airway Pressure (BPAP) Devices
  • Others
  • Masks and Accessories
  • Others
• Diagnostic Devices
  • Polysomnography Devices
  • Pulse Oximeter
  • Actigraphy Systems
  • Others

By End User

• Sleep Laboratories & Clinics
• Homecare & Other Settings

By Geography

• North America (By Device Type, By End User, and By Country)
  • U.S. (By Device Type)
  • Canada (By Device Type)
• Europe (By Device Type, By End User, and By Country/Sub-region)
  • U.K. (By Device Type)
  • Germany (By Device Type)
  • France (By Device Type)
  • Italy (By Device Type)
  • Spain (By Device Type)
  • Scandinavia (By Device Type)
  • Rest of Europe (By Device Type)
• Asia Pacific (By Device Type, By End User, and By Country/Sub-region)
  • Japan (By Device Type)
  • India (By Device Type)
  • China (By Device Type)
  • Australia (By Device Type)
  • Southeast Asia (By Device Type)
  • Rest of Asia Pacific (By Device Type)
• Latin America (By Device Type, By End User, and By Country/Sub-region)
  • Brazil (By Device Type)
  • Mexico (By Device Type)
  • Rest of Latin America (By Device Type)
• Middle East & Africa (By Device Type, By End User, and By Country/Sub-region)
  • South Africa (By Device Type)
  • GCC (By Device Type)
• Rest of the Middle East & Africa (By Device Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Prevalence of Sleep Apnea, By Key Country/ Regions, 2025
• 4.2. Technological Advancements in Sleep Apnea Devices
• 4.3. Key Industry Developments - Mergers, Acquisition, and Partnerships
• 4.4. Impact of COVID-19 on the Market

5. Global Sleep Apnea Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Device Type
  • 5.1.1. Therapeutic Devices
    • 5.1.1.1. Positive Airway Pressure Devices
      • 5.1.1.1.1. Continuous Positive Airway Pressure (CPAP) Devices
      • 5.1.1.1.2. Bilevel Positive Airway Pressure (BPAP) Devices
      • 5.1.1.1.3. Others
    • 5.1.1.2. Masks and Accessories
    • 5.1.1.3. Others
  • 5.1.2. Diagnostic Devices
    • 5.1.2.1. Polysomnography Devices
    • 5.1.2.2. Pulse Oximeter
    • 5.1.2.3. Actigraphy Systems
    • 5.1.2.4. Others
• 5.2. Market Analysis, Insights and Forecast - By End User
  • 5.2.1. Sleep Laboratories & Clinics
  • 5.2.2. Homecare & Other Settings
• 5.3. Market Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Sleep Apnea Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Device Type
  • 6.1.1. Therapeutic Devices
    • 6.1.1.1. Positive Airway Pressure Devices
      • 6.1.1.1.1. Continuous Positive Airway Pressure (CPAP) Devices
      • 6.1.1.1.2. Bilevel Positive Airway Pressure (BPAP) Devices
      • 6.1.1.1.3. Others
    • 6.1.1.2. Masks and Accessories
    • 6.1.1.3. Others
  • 6.1.2. Diagnostic Devices
    • 6.1.2.1. Polysomnography Devices
    • 6.1.2.2. Pulse Oximeter
    • 6.1.2.3. Actigraphy Systems
    • 6.1.2.4. Others
• 6.2. Market Analysis, Insights and Forecast - By End User
  • 6.2.1. Sleep Laboratories & Clinics
  • 6.2.2. Homecare & Other Settings
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
    • 6.3.1.1. By Device Type
  • 6.3.2. Canada
    • 6.3.2.1. By Device Type

7. Europe Sleep Apnea Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Device Type
  • 7.1.1. Therapeutic Devices
    • 7.1.1.1. Positive Airway Pressure Devices
      • 7.1.1.1.1. Continuous Positive Airway Pressure (CPAP) Devices
      • 7.1.1.1.2. Bilevel Positive Airway Pressure (BPAP) Devices
      • 7.1.1.1.3. Others
    • 7.1.1.2. Masks and Accessories
    • 7.1.1.3. Others
  • 7.1.2. Diagnostic Devices
    • 7.1.2.1. Polysomnography Devices
    • 7.1.2.2. Pulse Oximeter
    • 7.1.2.3. Actigraphy Systems
    • 7.1.2.4. Others
• 7.2. Market Analysis, Insights and Forecast - By End User
  • 7.2.1. Sleep Laboratories & Clinics
  • 7.2.2. Homecare & Other Settings
• 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.3.1. U.K.
    • 7.3.1.1. By Device Type
  • 7.3.2. Germany
    • 7.3.2.1. By Device Type
  • 7.3.3. France
    • 7.3.3.1. By Device Type
  • 7.3.4. Spain
    • 7.3.4.1. By Device Type
  • 7.3.5. Italy
    • 7.3.5.1. By Device Type
  • 7.3.6. Scandinavia
    • 7.3.6.1. By Device Type
  • 7.3.7. Rest of Europe
    • 7.3.7.1. By Device Type

8. Asia pacific Sleep Apnea Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Device Type
  • 8.1.1. Therapeutic Devices
    • 8.1.1.1. Positive Airway Pressure Devices
      • 8.1.1.1.1. Continuous Positive Airway Pressure (CPAP) Devices
      • 8.1.1.1.2. Bilevel Positive Airway Pressure (BPAP) Devices
      • 8.1.1.1.3. Others
    • 8.1.1.2. Masks and Accessories
    • 8.1.1.3. Others
  • 8.1.2. Diagnostic Devices
    • 8.1.2.1. Polysomnography Devices
    • 8.1.2.2. Pulse Oximeter
    • 8.1.2.3. Actigraphy Systems
    • 8.1.2.4. Others
• 8.2. Market Analysis, Insights and Forecast - By End User
  • 8.2.1. Sleep Laboratories & Clinics
  • 8.2.2. Homecare & Other Settings
• 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.3.1. Japan
    • 8.3.1.1. By Device Type
  • 8.3.2. China
    • 8.3.2.1. By Device Type
  • 8.3.3. India
    • 8.3.3.1. By Device Type
  • 8.3.4. Australia
    • 8.3.4.1. By Device Type
  • 8.3.5. Southeast Asia
    • 8.3.5.1. By Device Type
  • 8.3.6. Rest of Asia Pacific
    • 8.3.6.1. By Device Type

9. Latin America Sleep Apnea Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Device Type
  • 9.1.1. Therapeutic Devices
    • 9.1.1.1. Positive Airway Pressure Devices
      • 9.1.1.1.1. Continuous Positive Airway Pressure (CPAP) Devices
      • 9.1.1.1.2. Bilevel Positive Airway Pressure (BPAP) Devices
      • 9.1.1.1.3. Others
    • 9.1.1.2. Masks and Accessories
    • 9.1.1.3. Others
  • 9.1.2. Diagnostic Devices
    • 9.1.2.1. Polysomnography Devices
    • 9.1.2.2. Pulse Oximeter
    • 9.1.2.3. Actigraphy Systems
    • 9.1.2.4. Others
• 9.2. Market Analysis, Insights and Forecast - By End User
  • 9.2.1. Sleep Laboratories & Clinics
• 9.3. Homecare & Other Settings
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.4.1. Brazil
    • 9.4.1.1. By Device Type
  • 9.4.2. Mexico
    • 9.4.2.1. By Device Type
  • 9.4.3. Rest of Latin America
    • 9.4.3.1. By Device Type

10. Middle East & Africa Sleep Apnea Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Device Type
  • 10.1.1. Therapeutic Devices
    • 10.1.1.1. Positive Airway Pressure Devices
      • 10.1.1.1.1. Continuous Positive Airway Pressure (CPAP) Devices
      • 10.1.1.1.2. Bilevel Positive Airway Pressure (BPAP) Devices
      • 10.1.1.1.3. Others
    • 10.1.1.2. Masks and Accessories
    • 10.1.1.3. Others
  • 10.1.2. Diagnostic Devices
    • 10.1.2.1. Polysomnography Devices
    • 10.1.2.2. Pulse Oximeter
    • 10.1.2.3. Actigraphy Systems
    • 10.1.2.4. Others
• 10.2. Market Analysis, Insights and Forecast - By End User
  • 10.2.1. Sleep Laboratories & Clinics
  • 10.2.2. Homecare & Other Settings
• 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.3.1. GCC Countries
    • 10.3.1.1. By Device Type
  • 10.3.2. South Africa
    • 10.3.2.1. By Device Type
  • 10.3.3. Rest of Middle East & Africa
    • 10.3.3.1. By Device Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Koninklijke Philips N.V.
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Openairway
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Cadwell Industries, Inc.
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. ResMed
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Fisher & Paykel Healthcare Limited
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Invacare Corporation
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. SomnoMed
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Compumedics Limited
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Braebon Medical Corporation
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)